Blog
Read Newmanbrain latest blog publications.
![MCI detection with fNIRs device](https://newmanbrain.com/wp-content/uploads/2023/05/Captura-de-pantalla-2023-05-02-112707-768x430.png)
Early detection of MCI and fNIRs technology
MCI or Mild Cognitive Impairment, is a condition in which patients experiment a cognitive decline
May 2, 2023
![Newmanbrain's THEIA™ fNIRs portable device](https://newmanbrain.com/wp-content/uploads/2023/04/chica_theia_hands_diffuse_web-768x576.jpg)
THEIA™ Wins Prestigious Design Award
We are thrilled to announce that our latest fNIRs device, THEIA™, has been awarded an iF Design Award 2023.
April 14, 2023
![Newmanbrain's CEO and Project Manager in 100 startups Health](https://newmanbrain.com/wp-content/uploads/2023/03/photo_2023-03-28_10-49-03-768x576.jpg)
Newmanbrain among the 100 startups in healthcare
Last week, Newmanbrain participated in the 100 Startups Health event at La Nave in Madrid.
March 28, 2023
![Pablo Belmonte, Newmanbrain's CEO, presenting THEIA](https://newmanbrain.com/wp-content/uploads/2023/03/photo_2023-03-07_12-49-04-768x576.jpg)
Newmanbrain at the event AI Applied to Hospital Management
Last Friday March 3rd, Newmanbrain participated in the event “AI Applied to the Hospital Management”
March 7, 2023
![Pablo Belmonte (Newmanbrain CEO) in the IV IV edition of the rePCV](https://newmanbrain.com/wp-content/uploads/2022/12/201222-Ganadores-rePCV-PCUMH-768x453.jpg)
Newmanbrain awarded in the IV edition of the rePCV
Newmanbrain was awarded in the IV edition of the rePCV (Valencian Community Scientific Parks network)
December 20, 2022
![Pablo Belmonte (Co-founder & CEO) elevator pitch during the I European Artificial Intelligence Forum. / DAVID REVENGA](https://newmanbrain.com/wp-content/uploads/2022/12/9.1-768x512.jpg)
Newmanbrain awarded at the I European Artificial Intelligence Forum for its technology for biomedical use.
Newmanbrain, spin-off from the UMH Scientific Park, has recently been awarded at the I European
November 19, 2022